Rocuronium Has a Suppressive Effect on Platelet Function via the P2Y12 Receptor Pathway In Vitro That Is Not Reversed by Sugammadex
Rocuronium is an aminosteroid nondepolarizing neuromuscular blocker that is widely used for anesthesia and intensive care. In this study, we investigated the effect of rocuronium on human platelet functions in vitro. The effects of rocuronium on platelet aggregation, P-selectin expression, and cycli...
Main Authors: | Yutaka Murata, Shuji Kawamoto, Kazuhiko Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6399 |
Similar Items
-
Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
by: Gunn Hee Kim, et al.
Published: (2019-10-01) -
Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
by: Abdulhamid Alsaeed, et al.
Published: (2017-01-01) -
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01) -
Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
by: Woon Seok Kang, et al.
Published: (2017-04-01) -
Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
by: Kyo Sang Kim, et al.
Published: (2016-06-01)